211 related articles for article (PubMed ID: 16168853)
1. A three-dimensional computed tomography-assisted Monte Carlo evaluation of ovoid shielding on the dose to the bladder and rectum in intracavitary radiotherapy for cervical cancer.
Gifford KA; Horton JL; Pelloski CE; Jhingran A; Court LE; Mourtada F; Eifel PJ
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):615-21. PubMed ID: 16168853
[TBL] [Abstract][Full Text] [Related]
2. Comparison of dose distributions around the pulsed-dose-rate Fletcher-Williamson and the low-dose-rate Fletcher-Suit-Delclos ovoids: a Monte Carlo study.
Price MJ; Gifford KA; Horton J; Lawyer A; Eifel P; Mourtada F
Phys Med Biol; 2006 Aug; 51(16):4083-94. PubMed ID: 16885626
[TBL] [Abstract][Full Text] [Related]
3. Computed axial tomography tandem and ovoids (CATTO) dosimetry: three-dimensional assessment of bladder and rectal doses.
Gebara WJ; Weeks KJ; Hahn CA; Montana GS; Anscher MS
Radiat Oncol Investig; 1998; 6(6):268-75. PubMed ID: 9885943
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Monte Carlo calculations around a Fletcher Suit Delclos ovoid with radiochromic film and normoxic polymer gel dosimetry.
Gifford KA; Horton JL; Jackson EF; Steger TR; Heard MP; Mourtada F; Lawyer AA; Ibbott GS
Med Phys; 2005 Jul; 32(7):2288-94. PubMed ID: 16121584
[TBL] [Abstract][Full Text] [Related]
5. Development of prototype shielded cervical intracavitary brachytherapy applicators compatible with CT and MR imaging.
Price MJ; Jackson EF; Gifford KA; Eifel PJ; Mourtada F
Med Phys; 2009 Dec; 36(12):5515-24. PubMed ID: 20095264
[TBL] [Abstract][Full Text] [Related]
6. Point vs. volumetric bladder and rectal doses in combined intracavitary-interstitial high-dose-rate brachytherapy: correlation and comparison with published Vienna applicator data.
Yaparpalvi R; Mutyala S; Gorla GR; Butler J; Mah D; Garg MK; Kalnicki S
Brachytherapy; 2008; 7(4):336-42. PubMed ID: 18782683
[TBL] [Abstract][Full Text] [Related]
7. An analysis of the effect of ovoid shields in a selectron-LDR cervical applicator on dose distributions in rectum and bladder.
Steggerda MJ; Moonen LM; Damen EM; Lebesque JV
Int J Radiat Oncol Biol Phys; 1997 Aug; 39(1):237-45. PubMed ID: 9300759
[TBL] [Abstract][Full Text] [Related]
8. Bladder-rectum spacer balloon in high-dose-rate brachytherapy in cervix carcinoma.
Rai B; Patel FD; Chakraborty S; Sharma SC; Kapoor R; Aprem AS
Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):e217-22. PubMed ID: 23517809
[TBL] [Abstract][Full Text] [Related]
9. Computer tomography-assisted three-dimensional technique to assess rectal and bladder wall dose in intracavitary brachytherapy for uterine cervical cancer.
Sun LM; Huang EY; Ko SF; Wang CJ; Leung SW; Lin H; Wu JM; Wu IH; Lee SP
Radiother Oncol; 2004 Jun; 71(3):333-7. PubMed ID: 15172150
[TBL] [Abstract][Full Text] [Related]
10. Bladder-Rectum Spacer Balloon versus Vaginal Gauze Packing in High Dose Rate Brachytherapy in Cervical Cancer: A Randomised Study. Part II.
Rai B; Patel FD; Chakraborty S; Kapoor R; Sharma SC; Kumaravelu S; Raghukumar P; Aprem AS
Clin Oncol (R Coll Radiol); 2015 Dec; 27(12):713-9. PubMed ID: 26144319
[TBL] [Abstract][Full Text] [Related]
11. Comparison between CT-based volumetric calculations and ICRU reference-point estimates of radiation doses delivered to bladder and rectum during intracavitary radiotherapy for cervical cancer.
Pelloski CE; Palmer M; Chronowski GM; Jhingran A; Horton J; Eifel PJ
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):131-7. PubMed ID: 15850913
[TBL] [Abstract][Full Text] [Related]
12. Single versus customized treatment planning for image-guided high-dose-rate brachytherapy for cervical cancer: dosimetric comparison and predicting factor for organs at risk overdose with single plan approach.
Chi A; Gao M; Sinacore J; Nguyen NP; Vali F; Albuquerque K
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):309-14. PubMed ID: 19540070
[TBL] [Abstract][Full Text] [Related]
13. Monte Carlo model for a prototype CT-compatible, anatomically adaptive, shielded intracavitary brachytherapy applicator for the treatment of cervical cancer.
Price MJ; Gifford KA; Horton JL; Eifel PJ; Gillin MT; Lawyer AA; Mourtada F
Med Phys; 2009 Sep; 36(9):4147-55. PubMed ID: 19810488
[TBL] [Abstract][Full Text] [Related]
14. Image-guided cervix high-dose-rate brachytherapy treatment planning: does custom computed tomography planning for each insertion provide better conformal avoidance of organs at risk?
Davidson MT; Yuen J; D'Souza DP; Batchelar DL
Brachytherapy; 2008; 7(1):37-42. PubMed ID: 18299111
[TBL] [Abstract][Full Text] [Related]
15. Significance of ovoid separation with various applications of high-dose-rate-intracavitary radiotherapy in carcinoma of uterine cervix: a study from rural centre of Maharashtra, India.
Jain VS; Singh KK; Umberkar RB; Sarje MB; Jain SM
J Cancer Res Ther; 2010; 6(2):210-4. PubMed ID: 20622370
[TBL] [Abstract][Full Text] [Related]
16. The normal tissue sparing obtained with simultaneous treatment of pelvic lymph nodes and bladder using intensity-modulated radiotherapy.
Søndergaard J; Høyer M; Petersen JB; Wright P; Grau C; Muren LP
Acta Oncol; 2009; 48(2):238-44. PubMed ID: 18759144
[TBL] [Abstract][Full Text] [Related]
17. [Shielding of the adjacent organs in radiotherapy of cervical cancer on AGAT-B apparatus].
Minchenkova EA
Med Radiol (Mosk); 1991; 36(1):43-4. PubMed ID: 1996056
[TBL] [Abstract][Full Text] [Related]
18. Cone beam CT-based three-dimensional planning in high-dose-rate brachytherapy for cervical cancer.
Al-Halabi H; Portelance L; Duclos M; Reniers B; Bahoric B; Souhami L
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1092-7. PubMed ID: 19879059
[TBL] [Abstract][Full Text] [Related]
19. Effect of bladder distension on dose distribution of intracavitary brachytherapy for cervical cancer: three-dimensional computed tomography plan evaluation.
Cengiz M; Gürdalli S; Selek U; Yildiz F; Saglam Y; Ozyar E; Atahan IL
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):464-8. PubMed ID: 17768014
[TBL] [Abstract][Full Text] [Related]
20. A prospective three-dimensional analysis about the impact of differences in the clinical target volume in prostate cancer irradiation on normal-tissue exposure. A potential for increasing the benefit/risk ratio.
Hille A; Töws N; Schmidberger H; Hess CF
Strahlenther Onkol; 2005 Dec; 181(12):789-95. PubMed ID: 16362789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
